EFFICACY OF 2'3' DDI GIVEN ORALLY 2/DAY TO PATIENTS WITH AIDS OR ARC

艾滋病或弧光病患者每日 2 次口服 23 DDI 的功效

• 批准号: 3863488
• 负责人: HENRY S SACKS
• 金额: --
• 依托单位: MOUNT SINAI SCHOOL OF MEDICINE OF CUNY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3863488
• 关键词: 2'3' dideoxynucleoside; AIDS; AIDS therapy; disease /disorder prevention /control; drug tolerance; human subject; human therapy evaluation; infection; longevity; medical complication; oral administration

This study is designed to test the safety and effectiveness of a new drug Dideoxyiosine (DDI) in preventing infection and prolonging survival in HIV infected patients who are intolerant of zidovudine because of toxic effects on their blood cells.

这项研究的目的是测试一种新药的安全性和有效性